 |
|
A novel clinical trial for primary sclerosing cholangitis from Asia: All regional endeavors should improve global management of primary sclerosing cholangitis: Editorial on “Safety and efficacy of HK-660S in patients with primary sclerosing cholangitis: A randomized double-blind phase 2a trial”
Atsumasa Komori
Clin Mol Hepatol. 2025;31(2):584-588. Published online 2024 Nov 6 DOI: https://doi.org/10.3350/cmh.2024.0945
|
|
Citations to this article as recorded by
 Correspondence to editorial on “Safety and efficacy of HK-660S in patients with primary sclerosing cholangitis: A randomized double-blind phase 2a trial”
Woo Hyun Paik, Do Hyun Park
Clinical and Molecular Hepatology.2025; 31(2): e158. CrossRef
|